Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,146 | 49,458 | 60,087 | 93,526 | 113,999 |
| Receivables | 14,606 | 15,430 | 12,889 | 8,146 | 9,198 |
| Inventories | 58,736 | 48,584 | 35,443 | 28,695 | 26,010 |
| Other current assets | 11,924 | 12,142 | 11,130 | 11,199 | 15,571 |
| TOTAL | $126,412 | $125,614 | $119,549 | $141,566 | $164,778 |
| Non-Current Assets | |||||
| PPE Net | 3,846 | 4,097 | 4,347 | 4,521 | 4,698 |
| Intangibles | 3,208 | 3,208 | 3,208 | 3,208 | 3,208 |
| Other Non-Current Assets | 18,318 | 12,732 | 13,018 | 9,577 | 1,138 |
| TOTAL | $25,372 | $20,037 | $20,573 | $17,306 | $9,044 |
| Total Assets | $151,784 | $145,651 | $140,122 | $158,872 | $173,822 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 56,691 | 54,647 | 44,522 | 45,031 | 36,538 |
| Other current liabilities | 409 | 402 | 396 | 389 | 382 |
| TOTAL | $57,100 | $55,049 | $44,918 | $45,420 | $36,920 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,000 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 133,903 | 131,794 | 126,812 | 126,912 | 127,010 |
| TOTAL | $148,903 | $131,794 | $126,812 | $127,547 | $127,940 |
| Total Liabilities | $206,003 | $186,843 | $171,730 | $172,967 | $164,860 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 102,376 | 120,459 | 120,442 | 119,176 | 119,224 |
| Common Shares | 120 | 120 | 120 | 119 | 119 |
| Retained earnings | -1,058,331 | -1,041,336 | -1,019,818 | -998,538 | -968,109 |
| Other shareholders' equity | -357 | -357 | -357 | -357 | -357 |
| TOTAL | $-54,219 | $-41,192 | $-31,608 | $-14,095 | $8,962 |
| Total Liabilities And Equity | $151,784 | $145,651 | $140,122 | $158,872 | $173,822 |